Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
about
Fingolimod for relapsing-remitting multiple sclerosisComparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosisA randomized trial of teriflunomide added to glatiramer acetate in relapsing multiple sclerosis.Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.
P2860
Treatment options for patients with multiple sclerosis who have a suboptimal response to interferon-β therapy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Treatment options for patients ...... ponse to interferon-β therapy.
@en
type
label
Treatment options for patients ...... ponse to interferon-β therapy.
@en
prefLabel
Treatment options for patients ...... ponse to interferon-β therapy.
@en
P2860
P356
P1476
Treatment options for patients ...... ponse to interferon-β therapy.
@en
P2093
M S Freedman
P2860
P304
377-87, e18-20
P356
10.1111/ENE.12299
P577
2013-11-15T00:00:00Z